Volume 99, Issue S1 pp. 1376-1377
EDITORIAL

New balance to an old complex problem

Jack WC Tan

Corresponding Author

Jack WC Tan

National Heart Centre, Singapore, Singapore

Sengkang General Hospital, Singapore, Singapore

Correspondence Jack WC Tan, National Heart Centre, 5 Hospital Dr, Singapore 169609, Singapore.

Email: [email protected]

Search for more papers by this author
Sidney TH Lo

Sidney TH Lo

Liverpool Hospital, Sydney, New South Wales, Australia

Search for more papers by this author
Derek P Chew

Derek P Chew

College of Medicine and Public Health, Flinders University, Adelaide, South Australia, Australia

Search for more papers by this author
First published: 27 April 2022
No abstract is available for this article.

CONFLICTS OF INTEREST

Jack WC Tan reports honoraria from AstraZeneca, Bayer, Amgen, Medtronic, Abbott Vascular, Biosensors, Alvimedica, Boehringer Ingelheim, and Pfizer; research and educational grants from Medtronic, Biosensors, Biotronik, Philips, Amgen, AstraZeneca, Roche, Otsuka, Terumo, and Abbott Vascular; and consulting fees from Elixir and CSL Behring. Sidney TH Lo reports lecture honoraria from Bristol-Myers Squibb, Bayer, and Boehringer-Ingelheim; proctorship fees from Abbott, Boston Scientific, and Bioexcel; research funding from Abbot; and is an advisory board member for Abbott and Medtronic. Derek P Chew reports consulting fees from APSC; support for travel to meetings for the study or otherwise from APSC; grants/grants pending from Roche Diagnostics and AstraZeneca; and payment for development of educational presentations including service on speakers' bureaus from AstraZeneca.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.